NEPHROS, INC. Interest Expense Nonoperating
NEPHROS, INC. (NEPH) reported Interest Expense Nonoperating of $1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-08-10
- NEPHROS, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $1.00K, a 0.00% change year-over-year.
- NEPHROS, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $0.00.
- NEPHROS, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $0.00.
- NEPHROS, INC. interest expense nonoperating for the quarter ending 2025-06-30 was $1.00K.
- NEPHROS, INC. interest expense nonoperating for fiscal 2025 was $1.00K, a 0.00% change from fiscal 2024.
- NEPHROS, INC. interest expense nonoperating for fiscal 2024 was $1.00K, a 50.00% decline from fiscal 2023.
- NEPHROS, INC. interest expense nonoperating for fiscal 2023 was $2.00K.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-08-10 | $1.00K 10-Q · filed 2026-08-10 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $1.00K derived: sum of 3 quarters · filed 2026-08-10 | $1.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $1.00K derived: sum of 2 quarters · filed 2026-08-10 | $1.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $1.00K 10-Q · filed 2026-08-10 | $1.00K 10-Q · filed 2026-08-10 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 derived: sum of 3 quarters · filed 2026-03-12 | $1.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $1.00K 10-Q · filed 2025-11-06 | $2.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.00K 10-Q · filed 2025-08-07 | $2.00K derived: sum of 3 quarters · filed 2025-08-07 | $2.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.00K 10-Q · filed 2025-05-15 | $2.00K derived: sum of 2 quarters · filed 2025-05-15 | $2.00K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $1.00K derived: sum of 2 quarters · filed 2025-03-24 | $2.00K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.00K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $1.00K 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |